Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World Study
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World Study
Authors
Keywords
-
Journal
CNS DRUGS
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-07-19
DOI
10.1007/s40263-018-0543-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predictors of hematological abnormalities in multiple sclerosis patients treated with fingolimod and dimethyl fumarate and impact of treatment switch on lymphocyte and leukocyte count
- (2018) M. Baharnoori et al. Multiple Sclerosis and Related Disorders
- Emerging Understanding of the Mechanism of Action for Dimethyl Fumarate in the Treatment of Multiple Sclerosis
- (2018) Elizabeth A. Mills et al. Frontiers in Neurology
- Progressive multifocal leukoencephalopathy in patients treated with fumaric acid esters: a review of 19 cases
- (2017) Robbert-Jan Gieselbach et al. JOURNAL OF NEUROLOGY
- Dimethyl fumarate induces changes in B- and T-lymphocyte function independent of the effects on absolute lymphocyte count
- (2017) Erin E Longbrake et al. Multiple Sclerosis Journal
- Three-year clinical outcomes of relapsing multiple sclerosis patients treated with dimethyl fumarate in a United States community health center
- (2017) Kyle Smoot et al. Multiple Sclerosis Journal
- “No evident disease activity”: The use of combined assessments in the management of patients with multiple sclerosis
- (2017) Gavin Giovannoni et al. Multiple Sclerosis Journal
- Dimethyl fumarate induces changes in B- and T-lymphocyte function independent of the effects on absolute lymphocyte count
- (2017) Erin E Longbrake et al. Multiple Sclerosis Journal
- Three-year clinical outcomes of relapsing multiple sclerosis patients treated with dimethyl fumarate in a United States community health center
- (2017) Kyle Smoot et al. Multiple Sclerosis Journal
- “No evident disease activity”: The use of combined assessments in the management of patients with multiple sclerosis
- (2017) Gavin Giovannoni et al. Multiple Sclerosis Journal
- Safety and efficacy of dimethyl fumarate in multiple sclerosis: a multi-center observational study
- (2016) A. Miclea et al. JOURNAL OF NEUROLOGY
- Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis
- (2015) Tomas Kalincik et al. ANNALS OF NEUROLOGY
- Time course of clinical and neuroradiological effects of delayed-release dimethyl fumarate in multiple sclerosis
- (2015) L. Kappos et al. EUROPEAN JOURNAL OF NEUROLOGY
- Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients
- (2015) Erin E Longbrake et al. Multiple Sclerosis Journal
- PML in a Patient with Lymphocytopenia Treated with Dimethyl Fumarate
- (2015) Thorsten Rosenkranz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients
- (2015) Erin E Longbrake et al. Multiple Sclerosis Journal
- Dimethyl fumarate associated lymphopenia in clinical practice
- (2014) Erin E Longbrake et al. Multiple Sclerosis Journal
- Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
- (2012) Robert J. Fox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
- (2012) Ralf Gold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
- (2011) Chris H. Polman et al. ANNALS OF NEUROLOGY
- Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
- (2011) Ralf A. Linker et al. BRAIN
- Effect of BG-12 on contrast-enhanced lesions in patients with relapsing– remitting multiple sclerosis: subgroup analyses from the phase 2b study
- (2011) Ludwig Kappos et al. Multiple Sclerosis Journal
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search